Professional Documents
Culture Documents
PHARMACOGENETICS &
PERSONALIZED THERAPY
Personalized Medicine
• Medicine is personal:
– We are all different.
– Some of our differences translate into how we react to drugs
as individuals.
– This is why personalized medicine is important to
everyone.
• Why does someone need twice the standard dose to
be effective?
• Why does this drug work for you but not me?
• Why do I have side-effects and you don’t?
• Why do some people get cancer and others don’t?
The Goal of Personalized Medicine
• The Right Dose of
• The Right Drug for
• The Right Indication for
• The Right Patient at
• The Right Time.
Pharmacogenetics &
Pharmacogenomics
• Pharmacogenetics: Study of variability in drug
response determined by single genes.
🡪 study of individual gene-drug interactions, usually
one or two genes that have dominant effect on a drug
response (SIMPLE relationship)
• Pharmacogenomics: Study of variability in drug
response determined by multiple genes within the
genome.
🡪 study of genomic influence on drug response, often
using high-throughput data (sequencing, SNP chip,
expression, proteomics - COMPLEX interactions)
People react differently to drugs
Toxic responders
Non-responders
“One size does not fit all …” Responders
Genotyping
Patients with non-response
to drug therapy
Patient population
with same disease Patients with normal response
to drug therapy
phenotype
The aim of pharmacogenetics
• To make ‘personalized medicine’ as applicable
to various patient groups.
Potential causes of variability in drug effects
Autism (microdeletion),
Schizophrenia
(microduplication) on
16p11.2
CHROMOSOME
MUTATION
POINT MUTATION
SINGLE NUCLEOTIDE POLYMORPHISM
PHARMACOGENETICS POLYMORPHISM
Polymorphism and pharmacogenetics facts
1. DNA methylation.
2. Histone modification.
DNA methylation
Histon modification
CÁC YẾU TỐ GENE
ẢNH HƯỞNG ĐẾN
DƯỢC LỰC HỌC
RECEPTOR POLYMORPHISM
CONSEQUENCE OF POINT MUTATION
RECEPTOR POLYMORPHISM
ĐỘT BiẾN ĐiỂM TẠO TÍNH ĐA HÌNH TRÊN THỤ THỂ BETA 1
Đột biến sai nghĩa ở vị trí aa 389 tạo phiên bản Glycine 389
đáp ứng đảo ngược (inverse antagonist) so với phiên bản
Arginine 389 khi gắn kết với Carvedilol
CÁC YẾU TỐ GENE ẢNH HƯỞNG ĐẾN
DƯỢC ĐỘNG HỌC
BiỂU HiỆN GEN CỦA CÁC YẾU TÔ
CHUYỂN VẬN THUỐC
DRUG
TRANSPORTERS
EXPRESSION IN
HUMAN
HAI GIAI ĐOẠN CHUYỂN HOÁ THUỐC
MEN CHUYỂN HOÁ THUỐC KHÔNG PHẢI LÀ P450
β-
glucoronidase
Serotonine-N-acetyltransfer
ase
ACETYLCHOLINESTERASE
Tryptophan-84
Phenylalanine-3
30
Glutamic-199
Catechol-O-methyltransferas
e (COMT)
Monoamine oxidase A
(MAO)
https://www.pharmvar.org/genes
Ứ NG DỤNG TRÊN LÂM SÀNG
GENOTYPE-BASED DOSING
Effect of Metabolic Rate on Drug
Dosage